Publications by authors named "Joseph Pater"

Claim this Profile
F
Financial difficulty among patients with cancer participating in clinical trials and its association with patient survival and quality of life.
Bishal Gyawali, Nan Chen, Dongsheng Tu, Joseph Pater

J Natl Cancer Inst· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6.
Hira Mian, Jolie Ringash, Ralph Meyer, Annette E Hay, Lois Shepherd, Joseph Pater

Support Care Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group.
Louis Everest, Scott Blommaert, Dongsheng Tu, Joseph L Pater, Annette Hay

Value Health· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience.
Joseph C Del Paggio, Adam M Fundytus, Wilma M Hopman, Joseph L Pater, Bingshu E Chen

J Natl Cancer Inst· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials.
Matthew C Cheung, Kelvin Kw Chan, Shane Golden, Annette Hay, Joseph Pater

Clin Trials· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data.
Annette E Hay, Nicole Mittmann, Michael Crump, Matthew C Cheung, Jessica Sleeth, Joseph L Pater

Curr Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature.
Bethany E Monteith, Christopher P Venner, Donna E Reece, Andrea K Kew, Marc Lalancette, Joseph L Pater

Clin Lymphoma Myeloma Leuk· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses?
Timothy P Hanna, Paul Nguyen, Joseph Pater, Christopher J O'Callaghan, Nicole Mittmann

J Oncol Pract· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial.
Jeffrey S Hoch, Annette Hay, Wanrudee Isaranuwatchai, Kednapa Thavorn, Natasha B Leighl, Joseph Pater

BMC Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes.
Annette E Hay, Joseph L Pater, Elyse Corn, Lei Han, Ximena Camacho

Clin Trials· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mrs. Robinson's Revenge: Pete Seeger, Earl Robinson, and the Medicare Protest Song.
Jacalyn Duffin, Joseph L Pater

Can Bull Med Hist· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome.
Jose G Monzon, Annette E Hay, Gail T McDonald, Joseph L Pater, Ralph M Meyer

Eur J Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of registration of clinical trials units: the UK experience.
Eleanor McFadden, Saeeda Bashir, Steve Canham, Janet Darbyshire, Peter Davidson, Joseph Pater

Clin Trials· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.
Elizabeth Maunsell, Paul E Goss, Rowan T Chlebowski, James N Ingle, José E Alés-Martínez, Joseph L Pater

J Clin Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
James N Ingle, Daniel J Schaid, Paul E Goss, Mohan Liu, Taisei Mushiroda, Joseph Pater

J Clin Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stopping trials for benefit can (sometimes) benefit patients.
Joseph L Pater, Paul Goss, Ralph Meyer

J Clin Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an illustrative study in a palliative setting.
Michael Brundage, Andrea Bezjak, Dongsheng Tu, Michael Palmer, Joseph Pater

Expert Rev Pharmacoecon Outcomes Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
Hyman B Muss, Dongsheng Tu, James N Ingle, Silvana Martino, Nicholas J Robert, Joseph L Pater

J Clin Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
Paul E Goss, James N Ingle, Joseph L Pater, Silvana Martino, Nicholas J Robert

J Clin Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis.
Scott D Solomon, Janet Wittes, Peter V Finn, Robert Fowler, Jaye Viner, Joseph L Pater

Circulation· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example.
Joseph Pater, Dongsheng Tu, Lois Shepherd, James N Ingle, Paul E Goss

Breast Cancer Res Treat· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experience.
David Osoba, Andrea Bezjak, Michael Brundage, Joseph Pater,

Value Health· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.
Michael Brundage, David Osoba, Andrea Bezjak, Dongsheng Tu, Michael Palmer, Joseph Pater

J Clin Oncol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Paul E Goss, James N Ingle, Silvana Martino, Nicholas J Robert, Hyman B Muss, Joseph L Pater

J Clin Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
Deborah J Dudgeon, Eduardo Bruera, Bruno Gagnon, Sharon M Watanabe, Sharon J Allan, Joseph L Pater

J Pain Symptom Manage· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis